Compounds 1–11 were evaluated for their inhibitory activities against fructose-1,6-bisphosphatase, aldose reductase, lipase, dipeptidyl peptidase-IV, a-glucosidase, and three cancer cell lines. However, all the compounds showed weak or no activities in these tests.